Semperit AG Holding

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP
A76473122
SEDOL
B28LS48
CIK
N/A
semperitgroup.com
LEI:
©
FIGI: BBG000BC9KJ6
SEM
Semperit AG Holding
GICS: 20106020 · Sector: - · Sub-Sector: -
AI
PROFILER
NAME
Semperit AG Holding
ISIN
AT0000785555
TICKER
SEM
MIC
XWBO
REUTERS
SEM.VI
BLOOMBERG
SEM AV
BUILD THEMEFOLIO SHARE IDEAS DISCUSS
LEVERAGE INVEST
EN 728x90
Financial Intelligence
360° iHub Crowd iFeed ATH Tracker Index Tracker ETF TF Spicy2 X-Billboard
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Thu, 07.11.2024

Semperit increases profitability in Q1–3 and confirms outlook for 2024   EBITDA plus 12% to EUR 63.9 million, earnings after tax increase to EUR 7.1 million Free cash flow improves to EUR 22.4 million EBITDA guidance of around EUR 80 million confirmed for 2024   Vienna, November 7, 2024 – In the first three quarters of 2024, the Semperit Gro...
Research & Analysis
Read more
Thu, 26.09.2024

Semperit: Manfred Stanek appointed new CEO Vienna, 26 September 2024 – The Supervisory Board of Semperit AG Holding appointed Manfred Stanek as the new CEO of Semperit AG Holding today. He will join the Executive Board on 1March 2025 and take over the role of CEO on 1 April 2025; his mandate as a member of the Executive Board will run until 29 Fe...
Research & Analysis
Read more
Thu, 26.09.2024

Semperit: Manfred Stanek appointed new CEO Vienna, 26 September 2024 – The Supervisory Board of Semperit AG Holding appointed Manfred Stanek as the new CEO of Semperit AG Holding today. He will join the Executive Board on 1 March 2025 and take over the role of CEO on 1 April 2025; his mandate as a member of the Executive Board will run until 29 F...
Research & Analysis
Read more
Tue, 13.08.2024

Semperit increases profitability in the first half of 2024   EBITDA up 8% to EUR 47.3 million, earnings after tax more than doubled Free cash flow significantly improved to EUR 23.6 million Cost-cutting program takes effect: cost reductions of EUR 14.4 million, of which EUR 8.6 million in H1 EBITDA guidance confirmed at around EUR 80 million f...
Research & Analysis
Read more
Mon, 01.07.2024

Semperit finalizes sale of the remaining medical business Vienna, July 1, 2024 – Semperit has completed the sale of the medical business and transferred the remaining production and packaging of surgical gloves to the buyer of the entire medical business, the Southeast Asian Harps Global, as agreed. Combined under the discontinued operations “Surg...
Research & Analysis
Read more
Mon, 10.06.2024

Semperit: Executive Board Chairman Karl Haider will not extend his contract Vienna, June 10, 2024 – Karl Haider today informed the Chairman of the Supervisory Board of Semperit AG Holding that he will not be available for an extension of his Executive Board mandate, which expires on March 31, 2025. Karl Haider, who was appointed to the Executive B...
Research & Analysis
Read more
Mon, 10.06.2024

Semperit: Executive Board Chairman Karl Haider will not extend his contract Vienna, June 10, 2024 – Karl Haider today informed the Chairman of the Supervisory Board of Semperit AG Holding that he will not be available for an extension of his Executive Board mandate, which expires on March 31, 2025, and that he intends to focus more on non-executiv...
Research & Analysis
Read more
Wed, 15.05.2024

Semperit with stable revenue and 9% EBITDA increase in Q1 2024   Continued operations with revenue of EUR 176.0 million (–0.2%) and EBITDA of EUR 23.0 million (+9.4%) Cost reductions initiated in the previous year already reduced expenses by EUR 9.9 million, of which EUR 4.1 million was attributable to Q1 2024 EBITDA guidance of around EUR 80 ...
Research & Analysis
Read more
Tue, 19.03.2024

Semperit strengthened for further growth after transformation year – earnings 2023 still burdened by sold medical business   Continued operations with revenue of EUR 721.1 million (–7.5%), EBITDA of EUR 71.8 million (–28.5%) and positive earnings after tax of EUR 24.9 million (–35.2%) Cost reductions with a run rate of more than EUR 10 million p...
Research & Analysis
Read more
Tue, 05.03.2024

Semperit Executive Board proposes dividend of EUR 0.5 per share for 2023 Vienna, 5 March 2024 – The Executive Board of Semperit AG Holding has decided today to propose to the Annual General Meeting a dividend of EUR 0.5 per share for the financial year 2023. The Annual General Meeting of Semperit AG Holding will take place on 23 April 2024.    ...
Research & Analysis
Read more
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S